| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908724 | Leukemia Research | 2015 | 6 Pages |
Abstract
In this observational, population-based study, variations in ESA administration impacted response in transfusion-dependent MDS patients, with higher response rates with early administration and use of darbepoetin, and low response likelihood in non-responders beyond 16 weeks of therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Vu H. Duong, Maria R. Baer, Franklin Hendrick, Sheila R. Weiss, Masayo Sato, Amer M. Zeidan, Steven D. Gore, Amy J. Davidoff,